Prevalence of NAFLD in ACS Patients

The Prevalence of Non-Alcoholic Fatty Liver Disease in Patients With an Acute Cardiac Event Followed at Ziekenhuis Oost-Limburg, Genk, Belgium

Addressing CVD risk in patients with NAFLD is the aspect of the disease most amenable to medical management and so improving long-term clinical outcomes. Almost no studies have been done concerning the prevalence of NAFLD in CVD patients, most of the conducted studies have been done in already diagnosed NAFLD patients to estimate the risk of CVD development. Currently, there are no data available about the prevalence of NAFLD in CVD, more specifically patients with an acute cardiovascular event (ACE) in Belgium.

Inclusion Criteria:

• >18 years
• having acute cardiovascular syndrome
• able to understand Dutch
• able to understand the informed consent

Exclusion Criteria:

• excessive alcohol abuse
• other liver disease
• secondary causes of steatosis